GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Maven Brands Inc (XCNQ:MJ) » Definitions » EBITDA

Maven Brands (XCNQ:MJ) EBITDA : C$-0.72 Mil (TTM As of Dec. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Maven Brands EBITDA?

Maven Brands's EBITDA for the three months ended in Dec. 2022 was C$-0.23 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was C$-0.72 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Maven Brands's EBITDA per Share for the three months ended in Dec. 2022 was C$-0.01. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2022 was C$-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Maven Brands EBITDA Historical Data

The historical data trend for Maven Brands's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maven Brands EBITDA Chart

Maven Brands Annual Data
Trend Dec14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EBITDA
Get a 7-Day Free Trial Premium Member Only -3.92 -3.65 -11.18 -2.77 -1.80

Maven Brands Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.60 -0.19 -0.10 -0.20 -0.23

Competitive Comparison of Maven Brands's EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Maven Brands's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maven Brands's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Maven Brands's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Maven Brands's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Maven Brands's EBITDA for the fiscal year that ended in Mar. 2022 is calculated as

Maven Brands's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2022, Maven Brands's EBITDA was C$-1.80 Mil.

Maven Brands's EBITDA for the quarter that ended in Dec. 2022 is calculated as

Maven Brands's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2022, Maven Brands's EBITDA was C$-0.23 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Maven Brands  (XCNQ:MJ) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Maven Brands EBITDA Related Terms

Thank you for viewing the detailed overview of Maven Brands's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Maven Brands (XCNQ:MJ) Business Description

Traded in Other Exchanges
N/A
Address
100 Kalamalka Lake Road, Unit 32, Vernon, BC, CAN, V1T 9G1
Maven Brands Inc is a licensed producer of medicinal cannabis for the Canadian market under Canada's Marihuana for Medical Purposes Regulations program administered by Health Canada. The company is launching an innovative services program to provide seed-to-shelf solutions for cannabis micro-cultivators and small-scale producers across Canada. Its services will be designed to support craft growers on a path to the regulated market and will operate from the True Leaf Campus facility located in Lumby, British Columbia.